Related Experiment Video
Updated: May 23, 2025

10:25
Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
Published on: April 12, 2024
1.2K
Spot-Scanning Confocal Photon Beams for Hypofractionated Brain Radiosurgery.
Lijun Ma1, Shuang Luan2, Nguyen Phuong Dang1
1Department of Radiation Oncology, University of Southern California, Los Angeles, CA, USA.
Technology in Cancer Research & Treatment
|May 21, 2025
Summary
Dose kernel-based spot scanning (DKSC) offers a new, feasible method for hypofractionated brain stereotactic radiosurgery (SRS). This innovative technique, implemented on the Leksell Gamma Knife system, provides advantageous conformal dose distributions for brain tumor treatment.
Area of Science:
- Medical Physics
- Radiation Oncology
- Neurosurgery
Background:
- Stereotactic radiosurgery (SRS) is a standard treatment for brain tumors.
- Hypofractionated SRS aims to deliver higher doses in fewer fractions.
- Existing SRS delivery methods may have limitations in achieving optimal dose conformity.
Purpose of the Study:
- To develop and implement a novel dose kernel-based spot scanning (DKSC) treatment delivery technique for hypofractionated brain SRS.
- To evaluate the feasibility and advantages of DKSC compared to conventional SRS methods.
- To report on the clinical implementation workflow and planning considerations for DKSC on the Leksell Gamma Knife (LGK) system.
Main Methods:
- DKSC employs hundreds of confocal photon dose kernels placed along a continuous scanning path within the 3D target volume.
- Dose kernels of variable sizes, shapes, and beam weights were optimized to achieve conformal dose distributions.
- The DKSC technique was implemented and tested using the Leksell Gamma Knife (LGK) system.
Main Results:
- DKSC was successfully implemented for the first clinical patient treatment.
- The study reports the general methodology, specific workflow, and treatment planning considerations for DKSC on the LGK.
- A comparison highlighted the novelty and potential advantages of DKSC over conventional LGK-SRS treatments.
Conclusions:
- DKSC is technically feasible and clinically implementable for hypofractionated brain SRS.
- DKSC offers unique advantages for achieving conformal dose distributions in brain SRS.
- Further research is needed to explore DKSC for various SRS modalities and disease sites, including extra-cranial lesions.

